Rontalizumab
IFN-α | |
---|---|
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C6486H9990N1722O2026S44 |
Molar mass | 145917.93 g·mol−1 |
(what is this?) (verify) |
Rontalizumab is a
References
- ^ WHO Drug Information
- ^ Genentech: Rontalizumab (rhuMAb IFN alpha)
- ^ Clinical trial number NCT00962832 for "A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus (ROSE)" at ClinicalTrials.gov
- PMID 32185249.